Atara Biotherapeutics Inc. (ATRA)
NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ATRA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $94.05M
- Forward P/E
- 6.06
- EPS (TTM)
- -$1.25
- Dividend yield
- None
- 52-week range
- 3.92 – 19.15
- Day range
- 9.37 – 9.75
- Volume / Avg
- 11.45K / 54.79K
- Beta
- —
- Shares outstanding
- 10.04M
52-week range
ATRA stock today
On Oct 7, ATRA ended the session at $9.37, shedding $0.38 (3.90%), versus the S&P 500's 0.22% decline. Trading was light, with 11.45K shares changing hands, about 21% of the average daily volume. At this level, ATRA sits in the middle of its 52-week range of $3.92 to $19.15: 51.1% below the high, set on Jan 5, 2026 and 139.0% above the low.
ATRA is down 48.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 40.1%. Atara Biotherapeutics has posted a net loss over the last twelve months (EPS of -$1.25), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Atara Biotherapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2014
Atara Biotherapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CGTXCognition Therapeutics Inc. | 0.9366 | -0.36% | $89.06M | vs ATRA |
| NMRANeumora Therapeutics Inc. | 0.4683 | -0.57% | $87.99M | vs ATRA |
| CRDFCardiff Oncology Inc. | 1.09 | +1.87% | $84.80M | vs ATRA |
| BDTXBlack Diamond Therapeutics Inc. | 1.83 | +1.67% | $104.86M | vs ATRA |
| PTHSPelthos Therapeutics Inc. | 20.99 | -2.28% | $80.36M | vs ATRA |
| GRMLGreenland Mines Ltd. | 5.83 | -8.62% | $77.81M | vs ATRA |
| LENZLENZ Therapeutics Inc. | 3.62 | -4.49% | $113.74M | vs ATRA |
| OKYOOKYO Pharma Limited | 1.41 | -3.42% | $74.00M | vs ATRA |
Indexes, lists and sector
Atara Biotherapeutics stock FAQ
What is Atara Biotherapeutics's stock price today?
ATRA last traded at $9.37 as of Oct 7, 4:00 PM EDT, down 3.90% on the day. Prices are delayed at least 15 minutes.
Does Atara Biotherapeutics pay a dividend?
No. Atara Biotherapeutics does not currently pay a regular cash dividend.
Has ATRA ever split its stock?
Yes. The most recent ATRA stock split was a 1-for-25 split on Jun 20, 2024.
What is the ATRA 52-week high?
The 52-week high for ATRA is $19.15 and the 52-week low is $3.92. The stock is currently 51.1% below its high.